Monoclonal Antibodies Continue to Dominate Biopharmaceutical...

toegevoegd een audio Other

2025-12-01 10:38:21

Monoclonal Antibodies Continue to Dominate Biopharmaceutical Innovations Worldwide

Monoclonal antibodies (mAbs) are laboratory-engineered proteins designed to mimic the immune system’s ability to identify and neutralize harmful pathogens, cancer cells, and inflammatory triggers. They have become one of the most important classes of biopharmaceuticals used in the treatment of cancer, autoimmune disorders, infectious diseases, and chronic conditions. According to global...

0 Reacties 0 aandelen 16 Views 0 voorbeeld